Horizon Discovery, NIH enter research collaboration
Under the collaboration deal, NCI and NHGRI will apply Horizon’s rAAV gene editing technology (GENESIS) to engineer human isogenic disease models for its researchers. In addition, X-MAN (gene
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.